Timing of Transmural Stent Removal in Necrotizing Pancreatitis

Launched by THE FIRST AFFILIATED HOSPITAL OF NANCHANG UNIVERSITY · Jul 6, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the best time to remove metal stents in patients with a serious condition called necrotizing pancreatitis, which is a severe form of pancreatitis where the pancreas becomes inflamed and can develop dead tissue. In this study, participants will be randomly placed into two groups: one will have the stents removed during their last procedure to clean out the dead tissue, while the other will have them removed later, after their symptoms improve and imaging shows that the fluid buildup is almost gone. The main goal of the study is to see if the timing of stent removal affects the number of complications that might occur within three months.

To be eligible, participants need to be adults aged 18 to 65 who have been diagnosed with necrotizing pancreatitis and are able to give their consent to participate. However, those who have not had the metal stents placed, have different types of stents, or have other serious conditions like chronic pancreatitis or tumors are not eligible. If you or a loved one qualify, this study could provide valuable insights into the care of necrotizing pancreatitis and help improve treatment strategies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed with necrotizing pancreatitis according to the 2012 Atlanta classification criteria;
• • 2. Patients aged between 18 and 65 years;
• • 3. Patients who signed the informed consent;
• Exclusion Criteria:
• • 1. Patients without transmural stent placement;
• • 2. Patients with transmural plastic stent not metal stent placement before enrollment;
• • 3. Patients who underwent endoscopic transmural necrosectomy in other hospitals before admission;
• • 4. Patients complicated with chronic pancreatitis;
• • 5. Patients complicated with pancreatic tumor;
• • 6. Pregnant or lactating women.